Performance slump takes toll on Novartis' CEO's 2022 payout
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are working to help more people get access to the medicines they need #AccessinAction | Facebook
Novartis CEO explains how AI will impact drug development
BioCentury - Slimmed down Novartis is now poised to grow value, says CEO Narasimhan
Les jours de Vas Narasimhan à la tête de Novartis seraient comptés | Agefi.com
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
Vasant (Vas) Narasimhan | African Parks
CEO of Novartis pinning hopes on malaria drug | S-GE
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
CEO of Novartis pinning hopes on malaria drug - Basel Area Business & Innovation
Novartis appointed Vasant Narasimhan as CEO, effective February 1, 2018
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune
Novartis: Actares fustige la rémunération de la direction -Le 04 mars 2024 à 09:32 | Zonebourse
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Vas Narasimhan (@VasNarasimhan) / X
Novartis a plus que doublé son bénéfice en 2023 | L'Echo
It'll take more than vaccines to fight covid-19, says Novartis CEO Vas Narasimhan | Mint
Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
CEO pay: can Switzerland compete with the US? - SWI swissinfo.ch
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Novartis CEO Vas Narasimhan on Culture, Strategy and Change
